MYTELASE vs RESTASIS MULTIDOSE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. MYTELASE and RESTASIS MULTIDOSE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MYTELASE	RESTASIS MULTIDOSE
Rating	70/100	72/100
Pharmacy pays	—	~$52.85 /30
Type	RX	RX
Active ingredient	AMBENONIUM CHLORIDE	CYCLOSPORINE
Manufacturer	Sanofi Aventis US	Abbvie
Dosage forms	Tablet	Emulsion
Drug class	—	Calcineurin Inhibitor Immunosuppressant
Boxed warning	None	None
Half-life	—	about 8.4 hours (range 5 to 18 hours)
Treats	Myasthenia Gravis	Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

mytelase restasis multidose

Rating

70/100

72/100

Pharmacy pays

—

~$52.85 /30

Type

Active ingredient

AMBENONIUM CHLORIDE

CYCLOSPORINE

Manufacturer

Sanofi Aventis US

Abbvie

Dosage forms

Tablet

Emulsion

Drug class

—

Calcineurin Inhibitor Immunosuppressant

Boxed warning

None

Half-life

—

about 8.4 hours (range 5 to 18 hours)

Treats

Myasthenia Gravis

Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

Frequently asked questions

Which is better-rated, Mytelase or Restasis Multidose?

By our independent rating, Restasis Multidose scores higher — 3.6 vs 3.5 out of 5 for Mytelase. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Mytelase and Restasis Multidose?

Mytelase contains Ambenonium Chloride, while Restasis Multidose contains Cyclosporine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.